Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC has released an introductory seminar on market access for in-vitro diagnostic tests

Market access is a complex discipline that includes topics of reimbursement, funding, health technology assessment, clinical epidemiology, and stakeholder engagement.

At the moment, there is no good introductory training in market access for in-vitro diagnostic tests in Europe. Market access professionals develop an understanding of the disciple through work experience and conferences.

MTRC has bridged the gap with a seminar, aimed to give a brief, but comprehensive understanding of core concepts in the field of market access for IVD tests in Europe.

The seminar includes overview of topics of reimbursement, funding, payment mechanisms for IVD tests in hospital, day case and out-patient settings, health technology assessment, innovation funding, the role of clinical and economic evidence, stakeholder engagement.

The seminar includes general concepts of market access as well as some specifics of the market access situation in 10 EU countries (Austria, Belgium, England, France, Germany, Italy, Netherlands, Norway, Sweden and Switzerland).

The seminar is available as a pre-recorded on-demand webinar or full presentation in Acrobat PDF.

Learn more and request a quote here